Saul J. Priceman

University of Southern California — United States

Medicine · Health Sciences

34h-index8.6kcitations200works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(102), Immunotherapy and Immune Responses(42), Immune cells in cancer(38), Cancer Immunotherapy and Biomarkers(30), Virus-based gene therapy research(27)

Publications200 total

Current state of CAR-T cell therapies for solid tumors
Med·2026Open Access
An IL-12 renaissance: Engineering tumor-restricted IL-12 to improve solid tumor T cell therapies
Molecular Therapy·2025Open Access
Deciphering Resistance: Beyond the Androgen Paradigm; Report From the 2025 Coffey‐Holden Prostate Cancer Academy Meeting
The Prostate·2025Open Access
309 Combining radiopharmaceutical therapy with CAR T cells to overcome the heterogeneous immunosuppressive prostate tumor microenvironment
Regular and Young Investigator Award Abstracts·2025Open Access
CTIM-07. A PHASE 1 STUDY OF INTRAVENTRICULARLY ADMINISTERED AUTOLOGOUS HER2-TARGETING CHIMERIC ANTIGEN RECEPTOR T CELLS (HER2-CAR T CELLS), WITH AND WITHOUT LYMPHODEPLETION, IN HER2-POSITIVE BREAST CANCER PATIENTS WITH RECURRENT BRAIN AND/OR LEPTOMENINGEAL METASTASES
Neuro-Oncology·2025Open Access
Collagen-binding IL-12-armoured STEAP1 CAR-T cells reduce toxicity and treat prostate cancer in mouse models
Nature Biomedical Engineering·2025· 5 citedOpen Access
Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 delivery
Nature Biomedical Engineering·2025· 12 citedOpen Access
Intracranial metastases from solid tumors: Call to action and consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology collaborative
Neuro-Oncology·2025· 1 citedOpen Access
JAK2/STAT3 Signaling in Myeloid Cells Contributes to Obesity-Induced Inflammation and Insulin Resistance
Cells·2025· 1 citedOpen Access
Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors
Journal for ImmunoTherapy of Cancer·2025· 2 citedOpen Access
CD105+ fibroblasts support an immunosuppressive niche in women at high risk of breast cancer initiation
Breast Cancer Research·2025· 2 citedOpen Access
Whole-Proteome Screening and Multi-Modal Profiling of Antigen-Specific CD4+ T Cells at Single-Cell Resolution
2025Open Access
Author response for "Vascularized tumor-on-a-chip to investigate immunosuppression of CAR-T cells"
2025
Solid tumor CAR T cells engineered with fusion proteins targeting PDL1 for localized IL-12 delivery
2025Open Access
CD105+ fibroblasts support an immunosuppressive niche in women at high risk of breast cancer initiation
2025Open Access
<i>Collagen-binding IL-12 expressing</i> STEAP1 CAR-T cells reduce toxicity and eradicate mouse prostate cancer in combination with checkpoint inhibitors
2025· 1 citedOpen Access
Abstract A122: Improving antitumor T cell therapy with membrane-tethered engineered cytokine agonists (MECAs)
Cancer Immunology Research·2025
Abstract B001: Double targeted therapy PSCA-CAR-T cells and PSMA-radioligand in metastatic castration-resistant prostate cancer
Clinical Cancer Research·2025· 1 cited
Vascularized tumor-on-a-chip to investigate immunosuppression of CAR-T cells
Lab on a Chip·2025· 3 cited
Preclinical Proof of Concept for a personalized SNAP <sup>TM</sup> -TIL (Specific Neo-Antigen Peptides -TIL) therapy platform
2024
page 1 of 10Next →

Frequent Co-authors

Stephen J. Forman(20), Lily Wu(11), Hua Yu(10), Christine E. Brown(9), John P. Murad(9), Anthony K. Park(8), Wen-Chung Chang(6), Xiuli Wang(5), Andreas Herrmann(5), Dileshni Tilakawardane(5), Jiehui Deng(5), Shudan Shen(5), Maciej Kujawski(5), Lihong Weng(4), Julie R. Ostberg(4), Heehyoung Lee(4), Brook Jeang(4), Sumanta K. Pal(4), Yuman Fong(4), Sang‐In Kim(4)